clinical trial · NCT06344728
A Study to Assess the Relative Bioavailability of Brensocatib Pediatric Oral Solution to Oral Tablets in Healthy Participants
Healthy ParticipantsBrensocatib Oral SolutionBrensocatib Oral Tablet
brief summary
The primary purpose of this study is to determine the relative bioavailability of brensocatib between the pediatric oral solution and oral tablets in healthy participants.
started
Apr 30, 2024
primary completion
May 24, 2024
completion
May 24, 2024
last updated
Jun 13, 2024
official title
A Phase 1, Open-Label, Randomized, Two-Period Crossover Study to Assess the Relative Bioavailability of Brensocatib Pediatric Oral Solution to Oral Tablets Following Single Oral Doses in Healthy Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol